FDA Inspection 806330 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on October 25, 2012 in Monroe, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 25, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Monroe, LA (United States)